Genital herpes simplex virus infections: clinical manifestations, course, and complications

scientific article published on June 1983

Genital herpes simplex virus infections: clinical manifestations, course, and complications is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.7326/0003-4819-98-6-958
P698PubMed publication ID6344712

P50authorKing K. HolmesQ90437732
P2093author name stringCorey L
Brown ZA
Adams HG
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectsexual transmissionQ45349134
genital herpesQ7476596
P304page(s)958-972
P577publication date1983-06-01
P1433published inAnnals of Internal MedicineQ564416
P1476titleGenital herpes simplex virus infections: clinical manifestations, course, and complications
P478volume98

Reverse relations

cites work (P2860)
Q570765554 Herpes simplex virus infection in pregnancy
Q45796499A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection
Q35914367A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
Q45324468A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease
Q36397612A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM.
Q35648857A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes
Q30429126A rapid and simple isothermal nucleic acid amplification test for detection of herpes simplex virus types 1 and 2.
Q40558932A retrospective clinical, laboratory and outcome analysis in 43 cases of acute aseptic meningitis
Q35615364A review of famciclovir in the management of genital herpes
Q40210971A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
Q34291342Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy
Q69633728Acquired immunodeficiency syndrome manifested by chronic primary genital herpes
Q70176360Acquisition of neonatal HSV-1 infection from a paternal source contact
Q67912341Acute Urinary Retention Secondary to Herpes Simplex Meningitis
Q33933248Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention
Q68338044Acute urinary retention in herpes genitalis infection urodynamic evaluation
Q42947942Acute urinary retention preceding skin manifestations of genital herpes by 8 days
Q38078826Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management
Q40138670Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic Efficacy
Q33583052Acyclovir in first attacks of genital herpes and prevention of recurrences
Q40081290Acyclovir: New era in antiviral chemotherapy
Q40843184Advances in the treatment of herpesvirus infection: the role of famciclovir
Q33850188Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission
Q37860814An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence
Q39238300An overview application of silver nanoparticles in inhibition of herpes simplex virus.
Q33737719An overview of sexually transmitted diseases. Part I.
Q44911650Analysis of genomic polymorphism among herpes simplex virus type 2 isolates from four areas of Japan and three other countries
Q52664441Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
Q36978882Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.
Q40938400Antiviral chemotherapy in genital herpes simplex virus infections
Q24234315Antiviral therapy for genital herpes for prevention of HIV transmission
Q94355501Antiviral therapy for genital herpes for prevention of HIV transmission
Q33936755Are reported stress and coping style associated with frequent recurrence of genital herpes?
Q27489376Aseptic Meningitis and Viral Myelitis
Q36543596Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory
Q33856050Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes
Q45881313Atypical Presentations of Herpes Simplex Virus Infection
Q45835831Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2.
Q45778248Autopsy findings in two cases of neonatal herpes simplex virus infection: detection of virus by immunohistochemistry, in situ hybridization and the polymerase chain reaction
Q43822740Benign aseptic (Mollaret's) meningitis after genital herpes
Q36625969Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection.
Q37999153Chancroid and the role of genital ulcer disease in the spread of human retroviruses.
Q42938618Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88.
Q34193041Chemotherapy for herpes simplex virus infections
Q37863305Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells
Q45763302Clear detection and typing of herpes simplex virus types 1 and 2 by an indirect ELISA assay: comparison with three different combined methods--capture ELISA, restriction enzymes, and polymerase chain reaction.
Q37380356Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes
Q36729580Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection
Q69610617Clinical approach to urethritis, mucocutaneous lesions, and inguinal lymphadenopathy in homosexual men
Q33577281Clinical correlates of herpes simplex virus viremia among hospitalized adults
Q37229605Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir
Q64255293Co-infection of Herpes Simplex Virus Type 2 and HIV Infections among Pregnant Women in Ibadan, Nigeria
Q30417946Comparative clinical evaluation of the IsoAmp(®) HSV Assay with ELVIS(®) HSV culture/ID/typing test system for the detection of herpes simplex virus in genital and oral lesions
Q33951277Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics
Q37255330Comparative studies of types 1 and 2 herpes simplex virus infection of cultured normal keratinocytes
Q67486959Comparison of immunocytochemistry and in situ hybridization in the cytodiagnosis of genital herpetic infection
Q35331493Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences
Q37232489Comparison of standard culture methods, a shell vial assay, and a DNA probe for the detection of herpes simplex virus
Q37278010Comparison of the Scott Selecticult-HSV kit with conventional culture and direct immunoperoxidase staining for detection of herpes simplex virus in cultures of clinical specimens
Q37199777Comparison of the detection of herpes simplex virus in direct clinical specimens with herpes simplex virus-specific DNA probes and monoclonal antibodies
Q36170672Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses
Q89965378Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection
Q36630996Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding
Q22306018Current treatment options to prevent perinatal transmission of herpes simplex virus
Q33932423Cutaneous herpes simplex infections
Q35199402Cytodiagnosis of herpes simplex mastitis: Report of a rare case
Q45026813Demonstration of either endogenous recurrence or exogenous reinfection by resiriction endonuclease cleavage analysis of herpes simplex virus from patients with recrudescent genital herpes
Q37139285Design, synthesis and antiviral activity studies of schizonepetin derivatives.
Q35328407Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy
Q36544583Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria
Q36884252Detection of asymptomatic herpes simplex virus infections after vaccination
Q37224689Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines
Q37149121Detection of herpes simplex virus DNA from genital lesions by in situ hybridization
Q37189638Detection of herpes simplex virus by the Kodak SureCell Herpes Test
Q37905045Detection of herpesvirus cervicovaginitis by a sequential Papanicolaou--immunoperoxidase technique
Q37146168Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.
Q58609061Development of disease and immunity at the genital epithelium following intrarectal inoculation of male guinea pigs with herpes simplex virus type 2
Q35531465Diagnosis of genital herpes by real time PCR in routine clinical practice
Q37136139Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population
Q45807317Diagnosis of oral herpes simplex virus infections: Practical aspects of viral culture
Q45731556Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA.
Q36236667Differential association of ureaplasma species with non-gonococcal urethritis in heterosexual men.
Q39009035Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty
Q97646481Dynamics of HSV-2 infection with a therapeutic vaccine
Q40069410Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis
Q45833448Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus
Q52561266Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.
Q36517783Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women
Q38397126Epidural anaesthesia for caesarean section in patients with active recurrent genital herpes simplex infections: a retrospective review
Q31028568Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials
Q24187642Episodic therapy for recurrent genital herpes in non-immunocompromized adults
Q35530369Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2.
Q37879348Etiology of nongonococcal nonchlamydial urethritis
Q30654285Evaluation of ELVIS HSV ID/Typing System for the detection and typing of herpes simplex virus from clinical specimens
Q37269262Evaluation of a commercial enzyme-linked immunosorbent assay for detection of herpes simplex virus antigen
Q37278189Evaluation of a commercial enzyme-linked immunosorbent assay for the detection of herpes simplex virus
Q40190649Evaluation of a rapid latex slide agglutination test for herpes simplex virus as a specimen screen and culture identification method
Q47690917Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans
Q45286596Evaluation of some pyrazoloquinolines as inhibitors of herpes simplex virus type 1 replication
Q37266692Evaluation of the virocult transport tube for isolation of herpes simplex virus from clinical specimens
Q33959969Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera
Q43572238Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial
Q40918319Female genital tract discharge
Q39627155First-episode, recurrent, and asymptomatic herpes simplex infections.
Q45783859Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus
Q37364727Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment
Q33638754Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model
Q37886701From virus to vaccine: recombinant mammalian cell lines as substrates for the production of herpes simplex virus vaccines
Q30235026Genital Herpes: Insights into Sexually Transmitted Infectious Disease
Q28262599Genital herpes
Q83289688Genital herpes
Q77803098Genital herpes complicating pregnancy
Q42946571Genital herpes diagnosed by cervical cytology
Q33750736Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data
Q36029499Genital herpes in Canada: Deciphering the hidden epidemic
Q41349366Genital herpes simplex infection in women
Q37999154Genital herpes simplex virus infections
Q33614235Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States
Q74752054Genital herpes--how much of a public-health problem?
Q39519630Genital herpes. How to relieve patients' physical and psychological symptoms
Q43457575Genital herpes. Recommendations for comprehensive care
Q40828445Genital herpes. Type-specific antibodies for diagnosis and management
Q69801208Genital herpes: does knowledge lead to action?
Q40782518Genital herpes: natural history and treatment of acute episodes
Q45756364Genital recurrent infection occurring 6 months after meningitis due to the same herpes simplex virus type 2 (HSV-2) strain evidence by restriction endonuclease analysis
Q91384445Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data
Q33650105Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer
Q34212799Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the
Q28595739HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway
Q37262110Healthcare seeking and sexual behavior among patients with symptomatic newly acquired genital herpes
Q68158083Herpes Genitalis
Q28067618Herpes Genitalis: Diagnosis, Treatment and Prevention
Q38743245Herpes Mastitis: Diagnosis and Management
Q21562177Herpes Simplex Virus 2 ICP0− Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine
Q57269717Herpes Simplex Virus Infections in Solid Organ Transplant Recipients
Q34266498Herpes Simplex Virus Type 1 Is the Prevailing Cause of Genital Herpes in the Tel Aviv Area, Israel
Q37058139Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features
Q43597925Herpes diagnostic tests and their use.
Q36624483Herpes in pregnancy
Q33935057Herpes latency, meningitis, radiculomyelopathy and disseminated infection.
Q77803093Herpes management and prophylaxis
Q38672996Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes
Q55067552Herpes simplex encephalitis: a review.
Q35891431Herpes simplex mastitis: Case report and review of the literature
Q77304582Herpes simplex virus
Q36865265Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus
Q35767424Herpes simplex virus 2 infection rate and necessity of screening during pregnancy: a clinical and seroepidemiologic study
Q40844439Herpes simplex virus encephalitis in Peru: a multicentre prospective study.
Q36445515Herpes simplex virus encephalitis in children
Q42272329Herpes simplex virus in solid organ transplantation
Q33948597Herpes simplex virus infections
Q44285124Herpes simplex virus infections
Q72401503Herpes simplex virus infections
Q40782534Herpes simplex virus infections during the decade since the licensure of acyclovir
Q36699405Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes
Q35857276Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism
Q45770688Herpes simplex virus type 2 infection associated with urinary retention in the absence of genital lesions
Q35873842Herpes simplex virus type 2 inhibition of Fas ligand expression
Q34464387Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons
Q41717714Herpes simplex virus-2 infection. An emerging disease?
Q28236882Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding
Q96231075Herpes simplex virus: global infection prevalence and incidence estimates, 2016
Q34743418Herpes simplex viruses 1 and 2.
Q33660084Herpes vaccine
Q39217722Herpesvirus infections in pregnancy: risks to embryo, fetus, and neonate.
Q41046263Herpesvirus infections of the vulva
Q36717602Human antibodies from combinatorial libraries.
Q40855453Human cancer: molecular genetic and viral concepts and their influence in cytodiagnosis
Q71954670Human leukocyte interferon-alpha in cream for the management of genital herpes in Asian women: a placebo-controlled, double-blind study
Q69832268Humoral antibody response in patients with herpes genitalis: analysis of factors influencing the pattern of disease
Q36852943Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine
Q35089985Hyperaesthesia following genital herpes: a case report
Q35111489Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors
Q37393772Idiopathic urethritis in young men in the United States: prevalence and comparison to infections with known sexually transmitted pathogens
Q44437769IgG subclass of anti-HSV antibodies following neonatal HSV infections
Q33595097Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
Q39726771Immunologic basis for increased susceptibility of the neonate to infection
Q41687590Immunopathogenesis of herpetic ocular disease
Q34562540Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin
Q45369995In vitro anti-herpes simplex virus activity of 1,2,4,6-tetra-O-galloyl-β-D-glucose from Phyllanthus emblica L. (Euphorbiaceae).
Q35906911Incidence of Co-Infections of HIV, Herpes Simplex Virus Type 2 and Syphilis in a Large Cohort of Men Who Have Sex with Men in Beijing, China
Q35066312Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis
Q59350361Increased frequency of virus shedding by herpes simplex virus type 2-infected guinea pigs in the absence of CD4+ T lymphocytes
Q35569595Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes
Q77802801Infection and spread of alphaherpesviruses in the nervous system
Q36333902Infective Agents in the Central Nervous System
Q35575396Interferon in the prevention of genital herpes recurrence
Q35656655Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme
Q24201451Interventions for men and women with their first episode of genital herpes
Q38941189Interventions for men and women with their first episode of genital herpes.
Q43775536Intrauterine latent herpes simplex virus infection: I. Spontaneous abortion
Q40943318Iontophoresis for enhancing penetration of dermatologic and antiviral drugs
Q35530758Is HSV serology useful for the management of first episode genital herpes?
Q33934358Laboratory techniques in the diagnosis of herpes simplex infection
Q63740172Large, stable, contemporary interspecies recombination events in circulating human herpes simplex viruses
Q94291182Maladies à herpétoviridés: prévention et traitement: Partie 2. Epidémiologie et immunologie
Q37178782Male circumcision for the prevention of HSV-2 and HPV infections and syphilis
Q37837623Male non-gonococcal urethritis: From microbiological etiologies to demographic and clinical features
Q42249529Mammary herpes: a little known mode of neonatal herpes contamination
Q33939725Management of neonatal herpes simplex virus infection
Q45830234Management of oral and genital herpes simplex virus infections: diagnosis and treatment
Q40604634Management of the abnormal Papanicolaou smear
Q34354915Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry
Q44512626Maternal Herpes simplex virus type 2 encephalitis following Cesarean section
Q27347896Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa
Q46689697Meningitis after locoregional spinal anesthesia
Q45365651Mollaret's meningitis and herpes simplex virus type 2 infections
Q37904038Monoclonal antibodies for the diagnosis of sexually transmitted diseases.
Q34279175Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes
Q40521461Multicenter evaluation of the Luminex® ARIES® HSV 1&2 Assay for the detection of herpes simplex virus types 1 and 2 in cutaneous and mucocutaneous lesion specimens
Q39562986Natural history and pathogenesis of neonatal herpes simplex virus infections
Q35545367Neonatal herpes simplex infection
Q73214960Neonatal herpes simplex virus infection
Q70235875Neonatal herpes simplex virus infections
Q45732154Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients
Q41919381Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system
Q33815811Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro
Q33582145New concepts in understanding genital herpes
Q26746041Optimal management of genital herpes: current perspectives
Q30991218Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials
Q35562031Oral sex and the transmission of viral STIs
Q30582561Overview of acute and chronic meningitis
Q44204372Painless primary herpes
Q37419798Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans
Q37059518Performance of the Focus and Kalon Enzyme-Linked Immunosorbent Assays for Antibodies to Herpes Simplex Virus Type 2 Glycoprotein G in Culture-Documented Cases of Genital Herpes
Q40903260Perinatal herpesvirus infections. Herpes simplex, varicella, and cytomegalovirus
Q37295563Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition
Q34682912Persistent genital herpes simplex virus-2 shedding years following the first clinical episode
Q35543240Pharmacokinetics of acyclovir suspension in infants and children
Q69912315Placebo-controlled trial of topical interferon in labial and genital herpes
Q35236237Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection
Q35572847Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic
Q37201714Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
Q36173112Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
Q24670332Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia
Q39848661Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital
Q38933575Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil
Q33932926Preventing neonatal herpes?
Q57004506Prevention and control of herpesvirus diseases. Part 2. Epidemiology and immunology
Q37450218Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1.
Q59354827Primary Herpes Simplex Virus Infection Mimicking a Cervical Malignancy in an Immunocompetent Individual
Q35698595Primary herpes simplex virus infection mimicking cervical cancer
Q44644151Proinflammatory cytokines and chemokines - but not interferon-β - produced in response to HSV-2 in primary human genital epithelial cells are associated with viral replication and the presence of the virion host shutoff protein
Q72586720Properties of antiviral agents. 1
Q37547107Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs
Q36090597Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management.
Q37939941Psychosocial aspects of genital herpes: a review of the literature
Q40839973Psychosocial factors and recurrent genital herpes: a review of prediction and psychiatric treatment studies
Q33931849Psychosocial implications of recurrent genital herpes simplex virus infection
Q37265201Rapid diagnosis of herpes simplex virus infections by enzyme-linked immunosorbent assay
Q37694574Rapid host immune response and viral dynamics in herpes simplex virus-2 infection
Q36624531Rapid immunoassay for the detection of genital herpes infection
Q36776541Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract
Q33963713Recent progress in herpes simplex virus immunobiology and vaccine research
Q34959913Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro
Q37052019Reconsideration of viral protein immunoblotting for differentiation of human herpes simplex viruses
Q45807606Recovery of Epstein–Barr Virus from Genital Ulcers
Q33931593Recurrent genital herpes: clinical and virological features in men and women
Q33932337Recurrent genital tract infection: a result of induced immunosuppression?
Q37929715Recurrent intra-oral herpes simplex 1 infection
Q28375900Resveratrol inhibition of herpes simplex virus replication
Q35562163Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes
Q39741173Screening therapeutic insemination donors for sexually transmitted diseases: overview and recommendations
Q33583162Screening to detect asymptomatic shedding of herpes simplex virus (HSV) in women with recurrent genital HSV infection.
Q37221265Secreted herpes simplex virus-2 glycoprotein G alters thermal pain sensitivity by modifying NGF effects on TRPV1.
Q33931901Secretory IgA against herpes simplex virus in cervical secretions.
Q41206252Selected issues in premature rupture of the membranes: herpes, cerclage, twins, tocolysis, and hospitalization
Q45730664Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection
Q33917477Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya
Q37233274Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G
Q41753569Serum HSV-1 and -2 IgM in pregnant women in Port Harcourt, Nigeria
Q36151979Severe Primary HSV-2 in a Perinatal HIV-Infected Woman with Advanced Immunosuppression
Q50950429Sexually Transmitted Infections.
Q36520142Sexually transmitted cervicitis
Q40828451Sexually transmitted diseases. Present problems-future prospects
Q41703667Sexually transmitted esophagitis: primary herpes simplex virus type 2 infection in a healthy man.
Q35733995Sexually transmitted herpes simplex viruses
Q36987962Sexually transmitted viruses
Q93080827Shedding of the Salmonid Herpesvirus-3 by Infected Lake Trout (Salvelinus namaycush)
Q33973461Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population
Q37206230Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?
Q45845315Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia
Q40544353Synthesis of aldehydo-sugar derivatives of pyrazoloquinoline as inhibitors of herpes simplex virus type 1 replication
Q34092277The Acute Aseptic Meningitis Syndrome
Q33934554The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991.
Q56561856The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions
Q90577892The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study
Q30842506The herpesvirus proteases as targets for antiviral chemotherapy
Q35129410The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions
Q34730907The role of oral acyclovir in the management of genital herpes simplex
Q35540898Therapy of genital herpes with topically applied interferon
Q45851405Three cases of neonatal herpes simplex virus infection presenting as fulminant hepatitis
Q33583249Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study
Q68105188Toward the rational management of herpes infection in pregnant women and their newborn infants. Infectious Diseases and Immunization Committee, Canadian Paediatric Society
Q45238358Transmission of sexually transmitted diseases by donor semen
Q44820361Treatment of first-attack genital herpes--acyclovir versus inosine pranobex
Q45847830Treatment of herpes simplex virus infections.
Q37859744Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum
Q40076516Treatment of mucocutaneous herpes simplex infections
Q36144195Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis
Q45738818Typing of herpes simplex virus from human periodontium
Q67488109Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures
Q35169736Unusual initial presentation of herpes simplex virus as inguinal lymphadenopathy
Q34868359Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision
Q55406946Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
Q91766368Vaccines to prevent genital herpes
Q47189603Vagina dentata revisited: gender and asymptomatic shedding of genital herpes
Q36413848Vaginal discharge: an approach to diagnosis and management
Q64922869Vaginal infection of mice with HSV type 2 variant ER−: A new animal model for human primary genital HSV type 2 infections
Q36520204Vaginal infections.
Q42277082Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients
Q41460971Verbal intercourse and sexual communication: impediments to STD prevention
Q24669976Viral meningitis
Q30576590Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection
Q43047521Zika Virus Persistently and Productively Infects Primary Adult Sensory Neurons In Vitro
Q50740943[An epidemiological model of genital herpes for assessment of potential impact of therapy and prophylaxis: application to France]
Q79335121[Genital herpes]
Q76341636[Primary genital herpes with sacral meningoradiculitis]

Search more.